Integrated Filing — IndAS

General information about company
Scrip Code	500412
NSE Symbol	TIRUMALCHM
MSEI Symbol	NOTLISTED
ISIN	INE338A01024
Name of company	Thirumalai Chemicals Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	16-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	08-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Chemical products and its intermediaries
Start date and time of board meeting	16-May-2025   10:30:00
End date and time of board meeting	16-May-2025   14:05:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	5230600000	20495100000
	Other income	77800000	206000000
	Total income	5308400000	20701100000
2	Expenses
(a)	Cost of materials consumed	3708400000	15527800000
(b)	Purchases of stock-in-trade	429700000	466000000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-201000000	-126700000
(d)	Employee benefit expense	211300000	884700000
(e)	Finance costs	152700000	491500000
(f)	Depreciation, depletion and amortisation expense	183500000	611000000
(f)	Other Expenses
1	Other Expenses	933900000	3255300000
	Total other expenses	933900000	3255300000
	Total expenses	5418500000	21109600000
3	Total profit before exceptional items and tax	-110100000	-408500000
4	Exceptional items	0	0
5	Total profit before tax	-110100000	-408500000
6	Tax expense
7	Current tax	68900000	221400000
8	Deferred tax	-38400000	-168900000
9	Total tax expenses	30500000	52500000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	-140600000	-461000000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	-140600000	-461000000
17	Other comprehensive income net of taxes	-260400000	658000000
18	Total Comprehensive Income for the period	-401000000	197000000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	102400000	102400000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		8538800000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	-1.37	-4.5
	Diluted earnings (loss) per share from continuing operations	-1.37	-4.5
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	-1.37	-4.5
	Diluted earnings (loss) per share from continuing and discontinued operations	-1.37	-4.5
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		Notes: n1. The Audit Committee has reviewed, and the Board of Directors has approved the above results in their respective meetings held on 15 May n2025 and 16 May 2025. n2. In accordance with Ind AS 108, Operating Segments, the Group has identified manufacture and sale of organic chemicals as the only nreportable segment. n3. The standalone and consolidated financial results have been prepared in accordance with recognition and measurement principles laid down in nthe Indian Accounting Standard, prescribed under Section 133 of the Companies Act 2013, the Act, and other accounting principles generally naccepted in India and is in compliance with the presentation and disclosure requirements of the regulation 33 of the SEBI (Listing obligation and ndisclosure requirements) Regulations, 2015 as amended. n4. With respect to standalone and consolidated financial results, the figures for the quarters ended 31 March 2025 and 31 March 2024 represent nthe difference between the audited figures for the full financial years and the unaudited figures for the nine months ended 31 December 2024 and n31 December 2023, respectively. n

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	12513400000
	Capital work-in-progress	13521100000
	Investment property
	Goodwill	0
	Other intangible assets	1400000
	Intangible assets under development
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	1996000000
	Trade receivables, non-current
	Loans, non-current	0
	Other non-current financial assets	79900000
	Total non-current financial assets	2075900000
	Deferred tax assets (net)
	Other non-current assets	345600000
	Total non-current assets	28457400000
2	Current assets
	Inventories	2472700000
	Current financial asset
	Current investments	0
	Trade receivables, current	1989900000
	Cash and cash equivalents	1829100000
	Bank balance other than cash and cash equivalents	1744400000
	Loans, current	0
	Other current financial assets	69800000
	Total current financial assets	5633200000
	Current tax assets (net)	107000000
	Other current assets	1397200000
	Total current assets	9610100000
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	38067500000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	102400000
	Other equity	11454300000
	Total equity attributable to owners of parent	11556700000
	Non controlling interest
	Total equity	11556700000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	14006600000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
	Total Trade payable
	Other non-current financial liabilities	2055200000
	Total non-current financial liabilities	16061800000
	Provisions, non-current	138400000
	Deferred tax liabilities (net)	640100000
	Deferred government grants, Non-current
	Other non-current liabilities	410800000
	Total non-current liabilities	17251100000
	Current liabilities
	Current financial liabilities
	Borrowings, current	3059200000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	48800000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	4435500000
	Total Trade payable	4484300000
	Other current financial liabilities	1602300000
	Total current financial liabilities	9145800000
	Other current liabilities	64600000
	Provisions, current	49300000
	Current tax liabilities (Net)
	Deferred government grants, Current
	Total current liabilities	9259700000
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	26510800000
	Total equity and liabilites	38067500000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Re-measurement of defined benefit plans	4300000	800000
2	Equity instruments through other Comprehensive income, net	-256500000	602000000
	Total Amount of items that will not be reclassified to profit and loss	-252200000	602800000
2	Income tax relating to items that will not be reclassified to profit or loss	-36700000	95400000
3	Amount of items that will be reclassified to profit and loss
1	Exchange differences in translation of foreign operations	-3900000	118800000
2	Cash flow hedge reserve	-41000000	31800000
	Total Amount of items that will be reclassified to profit and loss	-44900000	150600000
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-260400000	658000000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			-408500000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			491500000
	Adjustments for decrease (increase) in inventories			45000000
	Adjustments for decrease (increase) in trade receivables, current			-141900000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-982100000
	Adjustments for decrease (increase) in other non-current assets			946800000
	Adjustments for other financial assets, non-current			-24200000
	Adjustments for other financial assets, current			15400000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-1238200000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			4400000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			611000000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			484300000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			24300000
	Adjustments for interest income			77200000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			-144500000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-34000000
	Net cash flows from (used in) operations			-442500000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			217900000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			-660400000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			22900000
	Purchase of property, plant and equipment			6129000000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			21000000
	Interest received			78800000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			585600000
	Net cash flows from (used in) investing activities	-5420700000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			13927200000
	Repayments of borrowings			8738200000
	Payments of lease liabilities			60300000
	Dividends paid			102400000
	Interest paid			1278600000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			3747700000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-2333400000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			106500000
	Net increase (decrease) in cash and cash equivalents			-2226900000
	Cash and cash equivalents cash flow statement at beginning of period			4056000000
	Cash and cash equivalents cash flow statement at end of period			1829100000